Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting

Laura Martelli, Anthony Lopez, Sophie Strobel, Silvio Danese, Xavier Roblin, Cédric Baumann, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To assess adherence to infliximab (IFX) therapy in inflammatory bowel disease patients, to investigate reasons for non-adherence and to identify predictors for non-adherence.

METHODS: This observational study was conducted in two French referral university hospitals between 1 September and 31 October, 2011. Patients were systematically asked if they had already delayed or missed an IFX perfusion since the beginning of the treatment and about the reasons for their non-adherence.

RESULTS: Of the 162 included patients (121 Crohn's disease [CD], 41 ulcerative colitis), 87 (53.7%) reported a delay of at least one IFX injection and 14 (8.6%) missed at least one IFX perfusion since the beginning of the treatment. The overall non-adherence rate was 54.3%. Pooling all misses, the main reasons for non-adherence were pregnancy (33.3%), intentional non-adherence (20%) and forgetfulness (13.3%). Pooling all delays, the main reasons for non-adherence were professional constraints (46.9%), infections (17.3%) and travels (14.3%). Perineal disease was associated with IFX delays (P = 0.0007, odds ratio 4.0), whereas active CD/UC was associated with IFX misses (P = 0.0258, OR = 5.4).

CONCLUSIONS: The overall non-adherence rate for IFX use was 54.3%. Professional constraints and intentional non-adherence were the leading causes of non-adherence. Perineal disease and active CD were negatively related to adherence.

Original languageEnglish
Pages (from-to)566-573
Number of pages8
JournalJournal of Digestive Diseases
Volume18
Issue number10
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting'. Together they form a unique fingerprint.

Cite this